Evidence map›Paper›PMID 29048278›Full record

ArticleEmerging infectious diseases2017

Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas.

Abinash Virk, Bobbi Pritt, Robin Patel, James R Uhl, Spencer A Bezalel, Lawrence E Gibson, Barbara M Stryjewska, Margot S Peters

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Emerging infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Diagnostic Value of 16S Ribosomal RNA Gene Polymerase Chain Reaction/Sanger Sequencing in Clinical Practice.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  3. Frontiers in microbiology · 2021
    Review
  4. Isolation of Mycobacterium lepromatosis and Development of Molecular Diagnostic Assays to Distinguish Mycobacterium leprae and M. lepromatosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Identification ofAnnals of dermatology · 2018
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Abinash Virk
Bobbi Pritt
Robin Patel
James R Uhl
Spencer A Bezalel
Lawrence E Gibson
Barbara M Stryjewska
Margot S Peters
Mayo Clinic in Arizona · USOffice of Infectious Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report Mycobacterium lepromatosis infection in a US-born person with an extensive international travel history. Clinical symptoms, histopathology, and management are similar to those of infections caused by M. leprae. Clinicians should consider this pathogen in the diagnosis of patients with symptoms of leprosy who have traveled to endemic areas.

Indexed as

ErythemaFaceHumansLeprosy, LepromatousMaleMiddle AgedMycobacteriumTravel16S ribosomal RNA gene PCRlepraelepromatosislepromatousleprosyMexicoMycobacteriumneuropathyrheumatoid arthritistouriststraveltuberculosis and other mycobacteriaUnited Statesvector-borne infectionszoonoses

Identifiers

PMID29048278
PMCPMC5652441
OpenAlexW2763862112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.